Skip to content

Effects of Alcohol Use Disorder on Sevoflurane Anesthetic Efficacy

Effects of Alcohol Use Disorder on Sevoflurane Anesthetic Efficacy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122230
Enrollment
Unknown
Registered
2026-04-10
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol use disorder

Interventions

Alcohol use disorder group:none
Control group:none

Sponsors

The Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years old, both male and female, ASA I-II level; 2. Patients with alcohol dependence: meet the diagnostic criteria for Alcohol Use Disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), with severity being moderate to severe (i.e., meeting >=4 symptom criteria), and an Alcohol Use Disorders Identification Test (AUDIT) score >=20; Non-drinking control patients: do not drink or drink very little (drinking <=2 times per month), with each drinking occasion <1 standard drink, and have not consumed alcohol in the past month; 3. Obtain informed consent from the patient and their family.

Exclusion criteria

Exclusion criteria: 1. Patients with severe systemic diseases, including liver and kidney failure, heart and respiratory failure, etc.; 2. Patients with a history of mental illness or neurological diseases (including history of cerebral infarction, brain trauma, and brain tumors, etc.); 3. Patients currently taking drugs that affect MACawake or with a history of drug abuse; 4. Patients with a family history of malignant hyperthermia or contraindications to sevoflurane; 5. Patients with hearing impairments; 6. Pregnant or postpartum women and patients with tumors, etc.; 7. Patients undergoing emergency surgery; 8. Patients with difficult airways or difficulty with mask ventilation; 9. Patients with other conditions that researchers deem unsuitable for participation in this study.

Design outcomes

Primary

MeasureTime frame
The MACawake value of sevoflurane in patients with alcohol use disorder;

Secondary

MeasureTime frame
The average minimum alveolar concentration of sevoflurane during loss and recovery of consciousness.;The BIS value of sevoflurane during loss and recovery of consciousness.;

Countries

China

Contacts

Public ContactYe Zhang

The Second Affiliated Hospital of Anhui Medical University

zhangye_hassan@sina.com+86 551 6386 9480

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026